Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri Lavillette

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Nature Medicine|April 26, 2011
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapyJoachim Lupberger, Mirjam B Zeisel, Fei Xiao, et al.
Nature Communications|July 27, 2022
Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
Nature Communications|July 31, 2021
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
EMBO Molecular Medicine|October 21, 2021
Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibodyTingting Li, Hongmin Cai, Yapei Zhao, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Nature Medicine|April 26, 2011
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapyJoachim Lupberger, Mirjam B Zeisel, Fei Xiao, et al.
Nature Communications|July 27, 2022
Author Correction: A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
Nature Communications|July 31, 2021
A synthetic nanobody targeting RBD protects hamsters from SARS-CoV-2 infectionTingting Li, Hongmin Cai, Hebang Yao, et al.
EMBO Molecular Medicine|October 21, 2021
Uncovering a conserved vulnerability site in SARS-CoV-2 by a human antibodyTingting Li, Hongmin Cai, Yapei Zhao, et al.
Pageof 8